Logo image
Development of a vaccine to protect koalas against koala retrovirus
Dissertation   Open access

Development of a vaccine to protect koalas against koala retrovirus

Solomon Olusola Olagoke
University of the Sunshine Coast, Queensland
Doctor of Philosophy, University of the Sunshine Coast
2020
DOI:
https://doi.org/10.25907/00180
pdf
PDF - Thesis3.49 MBDownloadView
ThesisPDF - Thesis Open Access

Abstract

koala retrovirus vaccine antibody
The long-term survival of the koala is under serious threat. Apart from the human-induced factors of habitat destruction, road accidents and domestic dogs, two infectious diseases pose major threats to koala survival. Although Chlamydia is the "most visible" of these infectious threats koala retrovirus (KoRV) is also important. KoRV infects the majority of Australia's koalas, with only some Victorian and South Australian koalas being KoRV negative (and these numbers are decreasing every year with new research). KoRV has been strongly linked to life threatening diseases such as lymphoma and leukemia. In addition to losses in wild koalas, some zoos have very high koala losses due to these diseases. While quarantine and antiretroviral drug treatment are possible control measures, they are impractical, leaving vaccination as the only realistic option in controlling KoRV infection and associated diseases. This PhD study was therefore set up to develop a vaccine with therapeutic properties to protect koalas against KoRV.

Details

Metrics

146 File views/ downloads
272 Record Views
Logo image